Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Higgins

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 3, 2011
Biocompatibility of pooled human immunoglobulin (Gamunex 10%™) with ocular infusion solutions (BSS™ and BSS Plus™): an in vitro evaluation of a potential antitoxin treatment for infectious endophthalmitisDennis P Han, William J O'Brien, Brian Higgins
Anticancer Research|April 1, 2009
Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenograftsKenneth Kolinsky, Yu-E Zhang, Ute Dugan, et al.
Plos One|August 11, 2012
BRAFV600E negatively regulates the AKT pathway in melanoma cell linesBrenden Chen, Christine Tardell, Brian Higgins, et al.
Breast Disease|June 4, 2010
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modelingTiffany A Traina, Ute Dugan, Brian Higgins, et al.
Molecular Cancer|May 5, 2011
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancerChristian Tovar, Brian Higgins, Kenneth Kolinsky, et al.
Biomedical Optics Express|May 28, 2016
Automatic detection of cone photoreceptors in split detector adaptive optics scanning light ophthalmoscope imagesDavid Cunefare, Robert F Cooper, Brian Higgins, et al.
Cell Cycle (Georgetown, Tex.)|September 4, 2010
Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapyChristian Tovar, Brian Higgins, Dayanand Deo, et al.
Investigational New Drugs|February 6, 2020
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemiaGeoffrey L Uy, Sarit Assouline, Anne-Marie Young, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2014
A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancerMova Leung, Joy Florendo, Jessica Kano, et al.
Leukemia|July 12, 2020
MDM2 inhibition: an important step forward in cancer therapyMarina Konopleva, Giovanni Martinelli, Naval Daver, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 3, 2011
Biocompatibility of pooled human immunoglobulin (Gamunex 10%™) with ocular infusion solutions (BSS™ and BSS Plus™): an in vitro evaluation of a potential antitoxin treatment for infectious endophthalmitisDennis P Han, William J O'Brien, Brian Higgins
Anticancer Research|April 1, 2009
Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenograftsKenneth Kolinsky, Yu-E Zhang, Ute Dugan, et al.
Plos One|August 11, 2012
BRAFV600E negatively regulates the AKT pathway in melanoma cell linesBrenden Chen, Christine Tardell, Brian Higgins, et al.
Breast Disease|June 4, 2010
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modelingTiffany A Traina, Ute Dugan, Brian Higgins, et al.
Molecular Cancer|May 5, 2011
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancerChristian Tovar, Brian Higgins, Kenneth Kolinsky, et al.
Biomedical Optics Express|May 28, 2016
Automatic detection of cone photoreceptors in split detector adaptive optics scanning light ophthalmoscope imagesDavid Cunefare, Robert F Cooper, Brian Higgins, et al.
Cell Cycle (Georgetown, Tex.)|September 4, 2010
Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapyChristian Tovar, Brian Higgins, Dayanand Deo, et al.
Investigational New Drugs|February 6, 2020
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemiaGeoffrey L Uy, Sarit Assouline, Anne-Marie Young, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2014
A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancerMova Leung, Joy Florendo, Jessica Kano, et al.
Leukemia|July 12, 2020
MDM2 inhibition: an important step forward in cancer therapyMarina Konopleva, Giovanni Martinelli, Naval Daver, et al.
Pageof 6